Search

Your search keyword '"Rob J van Marum"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Rob J van Marum" Remove constraint Author: "Rob J van Marum"
102 results on '"Rob J van Marum"'

Search Results

1. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial

2. Adherence with Dosing Guideline in Patients with Impaired Renal Function at Hospital Discharge.

5. Immunosuppressive Drugs and COVID-19: A Review

6. Dialysis or kidney transplantation in older adults? A systematic review summarizing functional, psychological, and quality of life-related outcomes after start of kidney replacement therapy

7. Older Patients’ Perceptions of Medicines and Willingness to Deprescribe

8. Kidney transplantation or dialysis in older adults-an interview study on the decision-making process

9. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards

10. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

11. To STOPP or to START? Potentially inappropriate prescribing in older patients with falls and syncope

12. General practice and patient characteristics associated with personal continuity: a mixed-methods study

13. A Systematic Review of the Current Evidence from Randomised Controlled Trials on the Impact of Medication Optimisation or Pharmacological Interventions on Quantitative Measures of Cognitive Function in Geriatric Patients

14. Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review

15. Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

16. Body weight gain in clozapine-treated patients: Is norclozapine the culprit?

17. Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine A Pragmatic Randomized Controlled Trial (CYSCE Trial)

18. New module about reducing and discontinuing of medication in the multidisciplinary guideline on polypharmacy in the elderly

19. Pharmacological management of osteoporosis in nursing home residents: the Shelter study

20. Underrepresentation of the elderly in clinical trials, time for action

21. Priority Setting in Improving Hospital Care for Older Patients Using Clinical Decision Support

23. Prevalence of Preventive Cardiovascular Medication Use In Nursing Home Residents. Room for Deprescribing? The SHELTER Study

24. Herziene module Medicatiebeoordeling beperkt werklast voor huisarts en apotheker

25. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study

26. Conversion of STOPP/START version 2 into coded algorithms for software implementation: A multidisciplinary consensus procedure

27. [Medicinal treatment of pain in the elderly: 10 tips from clinical pharmacology]]

28. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis

29. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels – a review of routine practice

30. Article Selected to Receive the Mitchell B. Balter Award for 2020

31. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data

32. O2‐09‐03: DIAGNOSTIC PERFORMANCE OF ELECSYS IMMUNOASSAYS FOR CEREBROSPINAL FLUID ALZHEIMER'S DISEASE BIOMARKERS IN A NON‐ACADEMIC MULTICENTER MEMORY CLINIC COHORT: THE ABIDE PROJECT

33. Prophylactic Use of Haloperidol and Changes in Glucose Levels in Hospitalized Older Patients

34. Predicting unsuccessful clozapine treatment after first use in adult patients with psychotic disorders

35. Deprescribing in newly admitted psychogeriatric nursing facility patients

36. Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients:A multi-centre double-blind randomised controlled clinical trial

37. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project

38. Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study

39. Haloperidol Does Not Activate Thrombogenic Factors in Older, Nonpsychotic Hospitalized Patients

40. Prevalence of correct anti-Xa levels in renally impaired patients who are on therapeutic nadroparin

41. Polypharmacy in nursing home residents with dementia

42. Mild chronic kidney disease is associated with cognitive function in patients presenting at a memory clinic

43. Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria

44. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades

45. Advanced Age and Female Sex As Risk Factors for High Anion Gap Metabolic Acidosis After a Drug Interaction Between Paracetamol and Flucloxacillin: A Case Series

46. [Spondylodiscitis in the elderly]

47. Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch general practice

48. Use of Rivastigmine or Galantamine and Risk of Adverse Cardiac Events: A Database Study from the Netherlands

49. Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study

50. An electronic system to document reasons for medication discontinuation and to flag unwanted represcriptions in geriatric patients

Catalog

Books, media, physical & digital resources